Tom 15, Nr 4 (2020)
Artykuł redakcyjny
Opublikowany online: 2021-03-04

dostęp otwarty

Wyświetlenia strony 463
Wyświetlenia/pobrania artykułu 183
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Praktyka kardiologa interwencyjnego w czasie pandemii SARS-CoV-2. Doświadczenia z różnych stron świata

Karol Nowak1, Jakub Furczyński1, Paweł Pasieka1, Aleksandra Karcińska1, Adam Stępień1, Patrycja Furczyńska1, Jarosław Zalewski1
Kardiol Inwazyjna 2020;15(4):179-184.

Streszczenie

Wybuch pandemii SARS-CoV-2 spowodował znaczne zmiany organizacyjne w zakresie ochrony zdrowia w Polsce i na całym świecie. Konieczne było opracowanie nowych wytycznych postępowania w różnych stanach chorobowych lub dostosowanie istniejących do obecnej sytuacji epidemiologicznej. W niniejszym opracowaniu przedstawiono wpływ pandemii koronawirusa na zapadalność na incydenty sercowo-naczyniowe, wyniki leczenia pacjentów kardiologicznych w ostatnich miesiącach w różnych krajach świata oraz na zmiany w dostępnych wytycznych postępowania z ostrymi zespołami wieńcowymi.

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–513.
  2. The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance (10.06.2020).
  3. Mahmud E, Dauerman HL, Welt FGP, et al. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020; 96(2): 336–345.
  4. Han Y, Zeng H, Jiang H, et al. CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic. Circulation. 2020; 141(20): e810–e816.
  5. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J . 2018; 39 : 119–177.
  6. Valente S, Anselmi F, Cameli M. Acute coronary syndromes during COVID-19. Eur Heart J. 2020; 41(22): 2047–2049.
  7. Spaccarotella CA, De Rosa S, Indolfi C. The effects of COVID-19 on general cardiology in Italy. Eur Heart J. 2020; 41(45): 4298–4300.
  8. Gąsior M, Gierlotka M, Tycińska A, et al. Effects of the coronavirus disease 2019 pandemic on the number of hospitalizations for myocardial infarction: regional differences. Population analysis of 7 million people. Kardiol Pol. 2020; 78(10): 1039–1042.
  9. Legutko J, Niewiara Ł, Bartuś S, et al. Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Poland during the coronavirus disease 2019 pandemic. Kardiol Pol. 2020; 78(6): 574–576.
  10. Rodriguez-Leor O, Cid-Álvarez B, de Prado AP, et al. Impacto de la COVID-19 en el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia española [Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience]. Rev Esp Cardiol. 2020; 10.
  11. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020; 106(23): 1805–1811.
  12. Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020; 396(10248): 381–389.
  13. De Rosa S, Spaccarotella C, Basso C, et al. Società Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020; 41(22): 2083–2088.
  14. Baldi E, Sechi GM, Mare C, et al. Lombardia CARe researchers. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart J. 2020; 41(32): 3045–3054.
  15. Worldometers.info. COVID-19 Coronavirus Pandemic Update. www.worldometers.info/coronavirus (22.12.2020).
  16. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(22): 2871–2872.
  17. Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5): 259–260.
  18. Shi S, Qin Mu, Shen Bo, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7): 802–810.
  19. Santoso A, Pranata R, Wibowo A, et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020 [Epub ahead of print].
  20. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 811–818.
  21. Bujak K, Kazik A, Wróbel M, et al. COVID-19 mimicking ST-elevation myocardial infarction. Postepy Kardiol Interwencyjnej. 2020; 16(2): 213–215.
  22. Jing ZC, Zhu HD, Yan XW, et al. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak. Eur Heart J. 2020; 41(19): 1791–1794.
  23. Xiang D, Xiang X, Zhang W, et al. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China. J Am Coll Cardiol. 2020; 76(11): 1318–1324.
  24. Watson RA, Johnson DM, Dharia RN, et al. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system. Hosp Pract (1995). 2020; 48(4): 169–179.
  25. Vlachakis PK, Tentolouris A, Kanakakis I. Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon. J Thromb Thrombolysis. 2020; 50(4): 809–813.
  26. Choudry FA, Hamshere SM, Rathod KS, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020; 76(10): 1168–1176.
  27. Dominguez-Erquicia P, Dobarro D, Raposeiras-Roubín S, et al. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur Heart J. 2020; 41(22): 2132.
  28. Zendjebil S, Zeitouni M, Batonga M, et al. Acute multivessel coronary occlusion revealing COVID-19 in a young adult. JACC Case Rep. 2020; 2(9): 1297–1301.
  29. Wang D, Hu Bo, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061–1069.